2026 mental health
Ozempic and addiction: What we know about GLP-1 medications and substance use
One of the most unexpected developments in addiction medicine has been the growing body of anecdotal and early clinical evidence suggesting that GLP-1 receptor agonists — medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) — may reduce cravings for alcohol, nicotine, and other substances.
What the research shows
GLP-1 receptors are present not only in the gut and pancreas but also in the brain's reward centers — the same regions implicated in addiction. Animal studies have consistently shown that GLP-1 agonists reduce alcohol consumption, nicotine self-administration, and cocaine-seeking behavior. In humans, anecdotal reports from patients on Ozempic for diabetes or weight loss describe spontaneous reduction in alcohol consumption, reduced interest in smoking, and decreased cravings for addictive substances. Early clinical trials specifically studying semaglutide for alcohol use disorder are underway, with preliminary results expected soon.
What it doesn't mean
It is far too early to recommend GLP-1 medications as an addiction treatment. The human evidence is primarily anecdotal, clinical trials are still in early phases, the mechanism of action for addiction reduction is not fully understood, side effects (nausea, gastroparesis, pancreatitis risk) are significant, and the medications are expensive ($800-$1,300/month without insurance). No addiction medicine organization currently recommends GLP-1 agonists for substance use disorders. Anyone considering these medications should do so under medical supervision for their approved indications.
Why it matters for the future
If clinical trials confirm the anti-addiction effects, GLP-1 medications could represent an entirely new pharmacological approach to addiction — one that works on the reward circuitry itself rather than simply blocking or replacing the substance. This is a space worth watching, and we will update this article as new research is published.
Treatment facilities in our directory
Related guides
How to choose a treatment center: The complete checklistWhat does insurance actually cover for addiction and mental health treatment?Understanding relapse: Why it happens and what to do nextHow much does rehab actually cost in 2026? A real breakdownRelated guides
How to choose a treatment center: The complete checklistWhat does insurance actually cover for addiction and mental health treatment?Understanding relapse: Why it happens and what to do nextHow much does rehab actually cost in 2026? A real breakdownDisclaimer: Informational only. Not medical advice. Need help? SAMHSA: 1-800-662-4357.